Journal of Evaluation in Clinical Practice

The Electronic Pharmaceutical Record: A new method for medication reconciliation

Early View

  • Author(s): Camille Jurado, Violaine Calmels, Emilie Lobinet, Elodie Divol, Hélène Hanaire, David Metsu, Brigitte Sallerin
  • Article first published online: 15 May 2018
  • DOI: 10.1111/jep.12942
  • Read on Online Library
  • Subscribe to Journal


Rationale, aim, and objective

There are several ways to establish an accurate medication list in the hospital admission medication reconciliation (MedRec). The challenge for MedRec lies in the availability, reliability, and completeness of the data used. In France, the Electronic Pharmaceutical Record (ePR) was developed to register each medication taken by ambulatory patients, primarily to make dispensation in community pharmacies safe.

We evaluated the suitability of this tool in the MedRec when patients were admitted to the hospital.


We conducted a 6‐month pilot study of 249 MedRec files from a hospital diabetology department. The analysis was supplemented by the ePR for any patient for whom this information was recorded. The study evaluated the ePR as a new MedRec tool, as well as the clinical impact (CI) of the new data collected.


The ePR was contributory for 28% of the patients. Discrepancies were associated with polypharmacy, most of which had a CI = 1. Medication omission was the most frequently found discrepancy (72%), but self‐medication (8%) and lack of medication adherence (9%) were also observed.


This tool provided added value for reconciliation, as it quickly identifies regular medications, adherence, and self‐medication behaviour. The ePR is essential for conducting a thorough MedRec.

Related Topics

Related Publications

Related Content

Site Footer


This website is provided by John Wiley & Sons Limited, The Atrium, Southern Gate, Chichester, West Sussex PO19 8SQ (Company No: 00641132, VAT No: 376766987)

Published features on are checked for statistical accuracy by a panel from the European Network for Business and Industrial Statistics (ENBIS)   to whom Wiley and express their gratitude. This panel are: Ron Kenett, David Steinberg, Shirley Coleman, Irena Ograjenšek, Fabrizio Ruggeri, Rainer Göb, Philippe Castagliola, Xavier Tort-Martorell, Bart De Ketelaere, Antonio Pievatolo, Martina Vandebroek, Lance Mitchell, Gilbert Saporta, Helmut Waldl and Stelios Psarakis.